Dermatologist Dr Andrew Pink shares practical clinical insights on managing patients receiving nemolizumab for atopic dermatitis, including treatment expectations, adverse event monitoring, and counselling strategies in routine practice.
Log In or Register as a healthcare professional to read the full article.
